Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Using simulated scenarios to train front-line staff in the COVID-19 response

Tucked away in an unassuming annexe at the back of the John Radcliffe Hospital you will find a powerhouse at the centre of training NHS staff on the COVID-19 front line. This is OxSTaR (Oxford Simulation, Teaching and Research), the University of Oxford’s state-of-the-art medical simulation, teaching and research facility. This unit, led by Dr Helen Higham, is part of the Nuffield Division of Anaesthetics in the Nuffield Department of Clinical Neurosciences. It embodies the incredible impact that can be achieved when robust research meets clinical practice — and never more so than in a global crisis such as the one in which we now find ourselves.

For 12 years, OxSTaR has been running simulated scenarios — complete with highly realistic functioning models of patients known as manikins — to understand and improve how healthcare professionals work together and interact with their environment and equipment. They have used the insights gained to provide training across Oxford University Hospitals (OUH). Recent weeks have seen them rise to the unique challenge of supporting front-line clinical staff during a pandemic. Helen is full of praise for everyone involved in this effort, particularly the members of her core team: Rosie Warren, Alan Inglis, Russ Sinclair, Charlie McDermott, Wendy Washbourn and Paul Hambidge. This outstanding example of the University and OUH working in partnership has also hinged on the enthusiastic engagement of OxSTaR’s faculty (largely anaesthetics and intensive care consultants and trainees), and support from OUH Infection Prevention and Control team, Corporate Education, the Chief Medical and Nursing Officers and Oxford Medical Imaging.

Read more on the University of Oxford Medium channel

Similar stories

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.